Know Cancer

or
forgot password

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses


N/A
18 Years
95 Years
Not Enrolling
Both
Actinic Keratosis

Thank you

Trial Information

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses


Inclusion Criteria:



- 18-95 years old

- Diagnosied with actinic keratoses.

Exclusion Criteria:

- Patients who have had Isotretinoin therapy less that 1 year prior to screening.

- Patients who have an adverse reaction to light exposure (for example photo-
exacerbated seizures).

- History of porphyria

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Actinic keratosis /incomplete therapy and reoccurence

Outcome Time Frame:

18 months

Safety Issue:

No

Principal Investigator

Maria Tsoukas, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Chicago

Authority:

United States: Institutional Review Board

Study ID:

15725A

NCT ID:

NCT00814528

Start Date:

November 2007

Completion Date:

May 2011

Related Keywords:

  • Actinic Keratosis
  • actinic keratosis
  • skin lesions
  • 5-ALA
  • AK
  • Blu-Light
  • Keratosis
  • Keratosis, Actinic
  • Ichthyosis
  • Keratoacanthoma

Name

Location

The University of ChicagoChicago, Illinois  60637